You're Taking Vitamin D and Still Deficient. Here's the Biological Reason.

The VDR gene codes for the vitamin D receptor, a protein that sits on the surface of your cells and acts like a lock. Vitamin D is the key. When vitamin D finds this receptor, it opens a cascade of genetic switches that regulate calcium metabolism, immune function, bone density, and mitochondrial energy production. Without a functional VDR, vitamin D can’t talk to your cells no matter how much you take.

The FokI variant in VDR comes in two lengths: short (ff) and long (FL or LL). Roughly 30-50% of people carry at least one copy of the longer version. The longer FokI variant is roughly 1.7 times less efficient at activating vitamin D signals in your cells. This means your cells need more vitamin D in the bloodstream to achieve the same biological effect. But there are other VDR variants too (BsmI and TaqI), and they all reduce how readily your cells recognize and respond to circulating vitamin D.

You may feel this as persistent fatigue despite normal bloodwork, bone aches that don’t improve with supplementation, poor immune function in winter despite taking vitamin D, or slow wound healing. Your bloodwork may show adequate vitamin D levels, but your cells are functionally starved because they can’t receive the signal.

Once vitamin D enters your bloodstream, it can’t float around loose. It must bind to a carrier protein called VDBP, coded by the GC gene. VDBP acts like a taxi service for vitamin D, ferrying it from your gut to your liver, kidneys, and target tissues. But here’s the critical detail: when vitamin D is bound tightly to VDBP, your cells can’t actually use it. Only the free, unbound fraction of vitamin D can enter cells and bind to the VDR receptor.

GC comes in three main haplotypes (1s, 1f, and 2), and they differ in how tightly they bind vitamin D and how much free vitamin D they leave available. Roughly 30-40% of the population carries a haplotype that binds vitamin D more tightly, leaving less free vitamin D available to tissues. You may have normal total bloodwork vitamin D but functionally low free vitamin D.

You experience this as vitamin D supplementation that doesn’t budge your symptoms, normal total vitamin D levels on labs but persistent bone pain, muscle weakness, or immune struggles. Your liver and kidneys are fine. Your GC variant is simply sequestering the vitamin D you’re taking.

BCMO1 codes for the enzyme that converts beta-carotene (the plant form of vitamin A found in carrots, sweet potatoes, and leafy greens) into retinol (the active animal form of vitamin A). Vitamin A is essential for immune function, epithelial cell integrity, and gene regulation. But this conversion step is genetically controlled, and many people can’t do it efficiently.

The R267S and A379V variants in BCMO1 impair the enzyme’s function. Roughly 45% of people carry at least one copy of a variant allele. People with BCMO1 variants can convert plant-based beta-carotene into retinol at only 20-50% of the standard rate. You can eat a kale salad and absorb almost no usable vitamin A from it. This is especially problematic because vitamin A and vitamin D metabolism are intertwined; poor vitamin A status worsens vitamin D dysfunction.

You notice this as poor immune function despite vitamin D supplementation, frequent infections, slow wound healing, poor night vision, or dry skin and hair. Your doctor sees normal bloodwork and assumes your diet is adequate. If you’re eating plant-based or Mediterranean, you’re especially vulnerable because you’re relying on a conversion step that your genes won’t perform.

Vitamin C is a cofactor for dozens of enzymes involved in collagen synthesis, immune function, and antioxidant defense. But vitamin C can’t cross your cell membrane on its own; it needs a transporter. SLC23A1 and SLC23A2 code for these transporters. Without functional transporters, vitamin C stays outside your cells, and you develop functional vitamin C deficiency despite adequate dietary intake.

Variants in SLC23A1 impair the transporter’s efficiency. Roughly 20-30% of people carry a variant. People with SLC23A1 variants have significantly reduced intracellular vitamin C accumulation despite normal blood levels, requiring roughly 2-3 times higher dietary intake to achieve cellular adequacy. This affects every downstream process that depends on vitamin C, including collagen cross-linking, immune cell function, and mitochondrial antioxidant defense.

You experience this as poor wound healing, weak immune function, joint pain or connective tissue laxity, poor skin quality, or fatigue despite taking vitamin C. Your bloodwork may show adequate vitamin C. But your cells are starved. This is especially problematic when combined with vitamin D dysfunction, because vitamin D and vitamin C work synergistically in immune regulation and collagen metabolism.

MTHFR codes for methylenetetrahydrofolate reductase, a critical enzyme in the methylation cycle that converts dietary folate into its active form, 5-methyltetrahydrofolate (5-MTHF). This process is the gateway to cellular energy production, neurotransmitter synthesis, detoxification, and immune function. When MTHFR is impaired, your entire methylation cycle stalls, and you develop functional folate and B12 deficiency even with adequate dietary intake.

The C677T variant, carried by roughly 40% of people of European ancestry, reduces MTHFR enzyme activity by 40-70%. People with C677T mutations can convert dietary folate into usable 5-MTHF at only 30-60% of the standard rate. The A1298C variant is less severe but compounds the problem if combined with C677T. You become functionally B vitamin depleted at the cellular level.

You feel this as severe fatigue despite normal B vitamin bloodwork, brain fog, mood instability, poor detoxification (feeling awful when you try to “clean up your diet”), joint pain, or recurrent infections. Vitamin D metabolism absolutely depends on B vitamins; your methylation cycle generates the cofactors needed to activate vitamin D in your kidneys and liver. If MTHFR is broken, vitamin D supplementation fails no matter the dose.

FUT2 codes for a fucosyltransferase that secretes ABO blood group antigens into your saliva, mucus, and gut lining. This sounds obscure, but it has a profound effect on which bacteria colonize your microbiome. Your microbiome, in turn, affects vitamin D absorption, B vitamin synthesis, and immune tolerance. People with certain FUT2 variants have dramatically different gut bacterial compositions and reduced capacity to absorb fat-soluble vitamins like vitamin D.

Roughly 40-50% of people carry a non-secretor FUT2 variant. Non-secretors have reduced capacity to support the bacteria that synthesize B vitamins and promote vitamin D absorption; their microbiomes are less diverse and less efficient at nutrient processing. Even if your VDR and GC genes are normal, poor FUT2 function can still block vitamin D absorption at the gut level.

You experience this as vitamin D deficiency despite supplementation, chronic digestive issues (bloating, loose stools, or constipation), B vitamin deficiency despite adequate diet, poor immune function, or food sensitivities. Your doctor checks your gut and finds nothing wrong on imaging. The problem is invisible: your bacterial composition is imbalanced in a way that prevents nutrient absorption and immune tolerance.